Tmall Medical Museum and other third -party online pharmaceutical trading platforms were called suspension of drug transactions，Many people mistakenly believe that all online pharmacies have been stopped。For this，Guangdong in the Internet pharmaceutical province，I can't sit still，Some enterprises speak to the outside world，Emphasizing the online transaction of a single online pharmacy，Still doing it as usual。

 

  People care about，& ldquo; How much impact does it affect the online pharmacy? Where is the transformation of online pharmacies?

 

  Multiple B2C pharmacies Emergency clarification

 

  When asked about the impact on the pharmaceutical e -commerce industry this time，Liu Guichun, vice chairman of the Guangdong Medical Retail Industry Association, admits: & ldquo; It has a certain stake online sports bettingimpact stake betting appon some of our early membership companies。& rdquo;

 

  Jianke.com CEO Xie Fangmin said，This stop will indeed reduce the trust of netizens' trust in online drug sales，Because many people mistakenly think that online pharmacies have been stopped。From the big influence，To some extent, it will reduce the investment in online medicine，Delaying the development speed of China's online drug trading market。

 

   & ldquo; First of all, to correct a misunderstanding，The three drugs that were stopped this time the third -party third -party platform of the Internet retail Internet，belonging to A Certificate Enterprise，Enterprise that gets A certificate，Only & lsquo; Drug production enterprise、Platform service providers between drug business enterprises and medical institutions & rsquo;。& rdquo;

 

  Xie Fangmin explanation，& ldquo; Internet drug trading service qualification certificate is divided into A certificate、B certificate、C certificate，Except A Certificate，B certificate companies can conduct drug transactions with other companies，C Certificate Enterprise can provide personal consumers with self -operated non -prescription drugs。There are currently more than 500 online pharmaceutical retail companies with C certificates with C certificates，It is not affected by stopping，It will continue to provide netizens and consumers with safe and high -quality online OTC drug trading services，Including Jianke。& rdquo;

 

  And Hu Feiqin, the marketing director of Kangzhijia, thinks，& ldquo; The outside world has suspected suspicions of the suspension of the pilot work of the third My stake betting app-party platform of drugs for Stake Sports Bettingthe drug。& rdquo; According to disclosure，Kang Zhijia's online drug sales performance has not declined。

 

  Pharmaceutical e -commerce maybe to start a diversion dispute?

 

  According to A Nalysys, the "Special Research Report Research Report 2016" data，All categories third -party B2C scale，about 70%-75%of the total scale。and the third -party B2C due to its standardization is not as good as self -operated B2C，OTC drug sales will be lower than self -operated B2C，Third-party B2C drug transaction accounts for about 50%-60%of the total B2C。

 

   Analysts Zhang Yidan told reporters from Nandu，In the short term，Relying on small -selling pharmaceutical platforms for third parties，Pharmacy with stable sales channels must be profitable，and pharmacies relying on third -party channels will be greatly affected。

 

   Liu Guichun also holds a similar point of view，Third -party drug sales platform pilot called stop，It means that the future investment of B 2C pharmacy will become larger。With the gradual popularization of online drugs，Accelerate the speed of the national card，Third -party drug sales platform for the diversion of the B 2C pharmacy is actually very high，But if you want to rely on B2C pharmacies to guide the traffic yourself，Investment in this area will be larger。

 

  In fact, the impact is not limited to B2C merchants that rely on platform traffic，Like Tmall、Jingdong、No. 1 store and other platform merchants，Also because of this & ldquo; stop & rdquo; I was accused of & ldquo;。

 

  Reporter observation

 

  Some platform merchants are borrowing resources to transform

 

  Ali Health announced a few days ago，Member stake online sports bettingof Tianjin Ruicheng, Member of the Chinese Medicine Stake Sports BettingO2O Pioneer Alliance、Ningbo Four Seasons Kanglai、More than 500 stores owned by Ruireang and Foshan Buddha's heart，5 edible oil varieties。

 

   & ldquo; Ali's health hopes that Chinese pharmacies are not just pharmacies，and can be like the US CVS mode，Become part of the healthy life of community residents。& rdquo; Chairman of the Chinese Medical O2O Pioneer Alliance Expert Committee、Alibaba Health Director Kang Kai Rush said。

 

   According to the reporter's understanding，Ali's self -employed pharmaceutical B2C website & ldquo; conscience big pharmacy & rdquo; online pharmacies (liangxinyao.com) officially launched，But the current name is still & ldquo; 5,000 -year -old pharmacy & rdquo;。Public information display，& ldquo; 5,000 years of pharmacies & rdquo; I acquired Ali Health at 16.8 million yuan in July this year。This medical retail chain pharmacy in Guangzhou，Although the company's performance in the past two years has become poor，and 2015 net profit is negative，But it has obtained the "Internet Drug Trading Service Qualification Certificate" on January 30, 2015。

 

  Another pilot platform、Eight hundred squares of the B2B business and the O2O business were announced before，Recently revealed to Nandu reporters，It has 100 O2O pharmacies in Guangzhou，Guangzhou local pharmaceutical e -commerce Kang Home，It adds up to 200 new O2O pharmacies。

 

  Jianke.com, which is about to complete the B financing，Treat pharmaceutical e -commerce more cautiously，Promote mobile medical treatment at the same time，Accelerate the layout online diagnosis。

 

   & ldquo;，Pharmaceutical Stake Sports Bettinge -commerce companies simply online B2C model will Stake Sports Bettingchange，Integration with the medical resources of the upper end of the industrial chain or integrate with the O2O model，Finally transformed from the drug sales platform to a medical pharmaceutical service platform。& rdquo; Zhang Yidan's judgment。